Ms. Robbins shares her challenging journey with cutaneous leishmaniasis, from misdiagnosis to founding the Leishmaniasis Advocacy Network. This interview from DNDi highlights urgent needs for awareness, affordable treatment, and patient-centered care.
For more than 30 years, physician Jill Seaman has treated infectious diseases through South Sudan Medical Relief in one of the world’s most remote and conflict-affected regions, saving thousands of lives in conditions most would consider impossible.
Delali Attipoe, Executive Director of DNDi North America, leads efforts to develop treatments for overlooked illnesses. Her work becomes increasingly vital as climate change spreads tropical diseases to new regions, including parts of the United States.
Existing treatments for leishmaniasis are antiquated and agonizing. But researchers at DNDi and PECAT are pioneering gentler, affordable solutions.